by Dr. Michael Garin | Mar 20, 2025 | Eye Care, Macular Degeneration
Burman and Zuckerbrod Ophthalmology is proud to announce that we’re one of only 14 practices nationwide offering the groundbreaking Lumithera Valeda treatment for dry macular degeneration (AMD). Recently approved by the FDA, this innovative therapy manages a condition...
by Dr. Michael Garin | Mar 13, 2025 | Eye Care, Eye Conditions, Macular Degeneration
The Valeda Lumithera device is one of the first treatments specifically designed to combine photobiomodulation (PBM) therapy with the treatment of dry macular degeneration (AMD). This innovative, non-invasive device uses light-based technology to target the underlying...
by Dr. Michael Garin | Mar 6, 2025 | Eye Care, Eye Conditions, Macular Degeneration
Photobiomodulation (PBM) therapy, also known as low-level light therapy (LLLT), is a groundbreaking treatment that utilizes specific wavelengths of light to stimulate cellular processes, promote healing, and reduce inflammation. PBM has shown great promise in various...
by Dr. Michael Garin | Feb 27, 2025 | Eye Care, Macular Degeneration
Age-related macular degeneration (AMD) is one of the leading causes of vision impairment, particularly in individuals over the age of 50. The condition affects the macula, the central part of the retina responsible for sharp vision. AMD is categorized into two forms:...
by Dr. Michael Garin | Oct 31, 2024 | Eye Care, Eye Conditions, General Health, Macular Degeneration
Pistachios are a nutritional powerhouse, not only because of their satisfying flavor and texture but also due to their high concentration of lutein. This potent antioxidant is essential for maintaining eye health and may play a role in reducing the risk of age-related...
by Dr. Michael Garin | Jan 11, 2024 | Eye Care, Eye Conditions, Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of central vision loss in adults over the age of 50. The early stages of AMD do not present many signs or symptoms. However, in advanced stages, patients will typically lose their ability to drive, see faces,...
